Molecule Details
| InChIKey | QXRSDHAAWVKZLJ-PVYNADRNSA-N |
|---|---|
| Compound Name | Epothilone B |
| Canonical SMILES | C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 15 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.46 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB03010 |
|---|---|
| Drug Name | Patupilone |
| CAS Number | 152044-54-7 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol. |
Categories: Anti-Bacterial Agents Antimitotic Agents Antineoplastic Agents Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Lactones Macrolides Mitosis Modulators Polyketides Tubulin Modulators
Cross-references: BindingDB: 50103627 ChEBI: 31550 CHEMBL94657 ChemSpider: 10213816 C12154 PDB: EPB PubChem:448013 PubChem:46505629 Therapeutic Targets Database: DNC000616 ZINC: ZINC000003951737
Target Activities (15)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P04350 | TUBB4A | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| P07437 | TUBB | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| P0DPH7 | TUBA3C | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| P68363 | TUBA1B | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| P68366 | TUBA4A | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| P68371 | TUBB4B | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q13509 | TUBB3 | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q13885 | TUBB2A | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q3ZCM7 | TUBB8 | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q6PEY2 | TUBA3E | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q71U36 | TUBA1A | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q9BQE3 | TUBA1C | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q9BUF5 | TUBB6 | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q9BVA1 | TUBB2B | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
| Q9H4B7 | TUBB1 | Homo sapiens | Human | PF00091 PF03953 | 8.5 | IC50 | ChEMBL |
DrugBank Target Actions (12)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P04350 | TUBB4A | Tubulin beta-4A chain | binder | targets |
| P07437 | TUBB | Tubulin beta chain | binder | targets |
| P0DPH7 | TUBA3C | Tubulin alpha 3C/D chain | binder | targets |
| P68363 | TUBA1B | Tubulin alpha-1B chain | binder | targets |
| P68366 | TUBA4A | Tubulin alpha-4A chain | binder | targets |
| P68371 | TUBB4B | Tubulin beta-4B chain | binder | targets |
| Q13509 | TUBB3 | Tubulin beta-3 chain | binder | targets |
| Q71U36 | TUBA1A | Tubulin alpha-1A chain | binder | targets |
| Q9BQE3 | TUBA1C | Tubulin alpha-1C chain | binder | targets |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | binder | targets |
| Q9NY65 | TUBA8 | Tubulin alpha-8 chain | binder | targets |